Abstract
As the ovary and placenta are endocrine organs, any neoplastic lesion arising from them may be active in hormone production. Although rare, they present interesting and challenging problems to clinicians. Hormone-producing ovarian tumors make up approximately 5% of all ovarian tumors. The histological diversity of these tumors is great and includes both primary and metastatic tumors of the ovary. Table 25–1 classifies these hormone-producing tumors into five major categories. Although androgens and estrogens are the most common hormones secreted by these tumors, human chorionic gonadotropin (hCG), thyroxine (T4), serotonin, and human placental lactogen (hPL) may be secreted as well. The clinical presentation is therefore extremely interesting in many of these cases. Although in vivo and in vitro studies of hormone production as well as ultrastructural studies have increased our understanding of these tumors, the histogenesis and pathophysiology of many of these tumors remains poorly understood.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
Morris J, Scully RE: Endocrine Pathology and the Ovary. St. Louis, Mosby, 1958
Norris HJ, Chorlton I: Functioning tumors of the ovary. Clin Obstet Gynecol 17: 189–228, 1974
Giuntoli RL, Celebre JA, Wu CH, et al: Androgenic function of a granulosa cell tumor. Obstet Gynecol 47: 77–79, 1976
Ireland K, Woodruff JD: Masculinizing ovarian tumors. Obstet Gynecol Surv 37: 603, 1982
Norris HJ, Taylor HB: Virilization associated with cystic granulosa tumors. Obstet Gynecol 34: 629–635, 1969
Taylor HC, Velasco ME, Flores SG, et al: Amenorrhea and failure to virilize in a patient with a testosterone secreting granulosa cell tumor. Clin Endocrinol 16: 557, 1982
Goldston WR, Johnston WW, Fetter BF, et al: Clinicopath- ologic studies in feminizing tumors of the ovary. Am J Obstet Gynecol 112: 422–429, 1972
Busby T, Anderson GW: Feminizing mesenchymomas of the ovary. Am J Obstet Gynecol 68: 1391–1420, 1954
Ryan KJ, Petro Z: Steroid biosynthesis by human ovarian granulosa and thecal cells. J Clin Endocrinol Metab 36: 46–51, 1966
Fox H, Agrawal K, Langley F: A clinical pathological study of 92 cases of granulosa cell tumors of the ovary with specific reference to the factors influencing prognosis. Cancer 35: 231, 1975
McDonald TW, Malkesian GD, Gaffey TA: Endometrial cancer associated with feminizing ovarian tumor and polycystic ovarian disease. Obstet Gynecol 49: 654–658, 1977
Evans AT, Gaffey TA, Malkasian GD, et al: Clinico-pathological review of 118 granulosa and 82 theca cell tumors. Obstet Gynecol 55: 231, 1980
Malkesian GD, Webb MJ, Jorsensen ED: Observations on chemotherapy of granulosa cell carcinomas and malignant ovarian teratomas. Obstet Gynecol 44: 885, 1974
Nokes JM, Claiborne HA, Reingold WN: Thecoma with associated virilization. Am J Obstet Gynecol 78: 722, 1959
Blaustein A (ed): Pathology of the Female Genital Tract 2nd ed. New York, Springer-Verlag, 1982
Teilum G: Classification of testicular and ovarian androblastoma and Sertoli cell tumors. Cancer 11: 769, 1958
Mandel FP, Voet RL, Weiland AJ, et al: Steroid secretion by masculinizing and feminizing hilus cell tumors. J Clin Endocrinol Metab 52: 779, 1981
Judd HL, Spore WW, Talner LB, et al: Preoperative localization of a testosterone-secreting ovarian tumor by retrograde venous catheterization and selective sampling. Am J Obstet Gynecol 120: 91, 1974
Weiland AJ, Bookstein JJ, Cleary RE, et al: Pre-operative localization of virilizing tumors by selective venous sampling. Am J Obstet Gynecol 131: 798, 1978
Lamberts SWJ, Timmers JM, Oosterom R, et al: Testosterone secretion by cultured adrenoblastoma cells: Suppression by a luteinizing hormone-releasing hormone agonist. J Clin Endocrinol Metab 54: 450, 1982
Muremura M, Nakamura T, Matsuura K, et al: Endocrine profile of an ovarian androblastoma. Obstet Gynecol 59: 100 (S), 1982
Meyer R: Pathology of some special ovarian tumors and their relation to sex characteristics. Am J Obstet Gynecol 26: 505, 1933
Ober WB, Pollak A, Gerstman KE, et al: Krukenberg tumor with androgenic and progestational activity. Am J Obstet Gynecol 84: 739, 1962
Cotton DB, Hanson FW, et al: A mucinous cystadenoma associated with testosterone production. J Reprod Med 26: 276, 1981
Woodruff JD, Williams TJ, Goldberg B: Hormone activity of the common ovarian neoplasm. Am J Obstet Gynecol 87: 679, 1963
Judd HL, Scully RE, Atkins L, et al: Pure gonadal dysgenesis with progressive hirsutism. N Engl J Med 282: 881, 1970
Swyer GIM: Male pseudo-hermaphroditism: A hitherto undeserved form. Br Med J 2: 709, 1955
Brewer JI, Rhinehart JJ, Dunbar RW: Choriocarcinoma: Report of 5 or more years survival from Albert Matthieu Chorionepithelioma Registry. Am J Obstet Gynecol 81: 574, 1961
Bardin DW, Rosen S, Lemaire WJ: In vivo and in vitro studies of androgen metabolism in a patient with pure gonadal dysgenesis and Leydig cell hyperplasia. J Clin Endocrinol 29: 1429, 1969
Creasman WT, Fetter BF, Hammond CB: Germ cell malignancies of the ovary. Obstet Gynecol 53: 226, 1979
Felmus LB, Pedowitz P: Clinical malignancy of endocrine tumors of the ovary and dysgerminoma. Obstet Gynecol 29: 344, 1967
Mueller DW, Topkins P, Lapp WA: Dysgerminoma of the ovary. Am J Obstet Gynecol 60: 153, 1950
Talerman A, Huyzinga WT, Kuiper T: Dysgerminoma: Clinicopathologic study of 22 cases. Obstet Gynecol 41: 136, 1973
Asadourian LA, Taylor HB: Dysgerminoma: An analysis of 105 cases. Obstet Gynecol 33: 370, 1969
Usizima H: Ovarian dysgerminoma associated with masculinization. Cancer 9: 736, 1956
Hain AM: An unusual case of precocious puberty associated with ovarian dysgerminoma. J Clin Endocrinol Metab 9: 1349, 1949
Neigus I: Ovarian dysgerminoma with chorioepithelioma. Am J Obstet Gynecol 69: 838, 1955
Ross GT, Goldstein DP, Hertz R, et al: Sequential use of methotrexate and Actinomycin D in treatment of metastatic choriocarcinoma and related trophoblastic disease in women. Am J Obstet Gynecol 93: 223–229, 1965
Smith JP, Rutledge F; Advances in chemotherapy for gynecologic cancer. Cancer 36: 669, 1975
Jacobs AJ, Newland JR, Green RK: Pure choriocarcinoma of the ovary. Obstet Gynecol Surv 37: 603, 1982
Van Nagell JR: Tumor markers in ovarian cancer. Clin Obstet Gynecol 10: 197 - 212, 1983
Smith FG: Pathology and physiology of struma ovarii. Arch Surg 53: 603, 1946
Woodruff JD, Markley RL: Struma ovarii: Demonstration of both pathologic change and physiologic activity; report of four cases. Obstet Gynecol 9: 707, 1957
Gonzalez-Angulo A, Kaufman RH, Braungardt CD, et al: Adenocarcinoma of thyroid arising in struma ovarii. Obstet Gynecol 9: 1349, 1949
Pardo-Mindau FJ, Vasquez JJ: Malignant struma ovarii: Light electron microscopic study. Cancer 51: 337, 1983
Woodruff JD, Rauh JT, Markley RL: Ovarian struma. Obstet Gynecol 27: 194, 1966
Robboy S J, Norris HJ, Scully RE: Insular carcinoid primary in the ovary. Cancer 36: 404, 1975
Serratoni FT, Robboy SJ: Ultrastructure of primary and metastatic ovarian carcinoids: Analysis of 11 cases. Cancer 36: 157, 1975
Kurman RJ, Norris HJ: Malignant mixed germ cell tumors of the ovary. Obstet Gynecol 48: 579, 1976
Kedzia H: Gonadoblastoma: Structures and background of development. Am J Obstet Gynecol 147: 81, 1983
Scully RE: Gonadoblastoma: A review of 74 cases. Cancer 25: 1340, 1970
Sternberg WH, Barclay DL: Luteoma of pregnancy. Am J Obstet Gynecol 95: 165, 1966
Garcia-Bunuel R, Berek JS, Woodruff JD: Luteomas of pregnancy. Obstet Gynecol 45: 407, 1975
Jewelewicz R, Perkins RP, Dyrenfurth I, Vande Wiele RL: Luteomas of pregnancy: A cause for maternal virilization. Clin Obstet Gynecol 17: 229, 1974
Zander J, Mickan H, Holzman K, et al: Androluteoma syndrome of pregnancy. Am J Obstet Gynecol 130: 170, 1978
Rice BF, Barclay DL, Sternberg WH: Luteoma of pregnancy: Steroidogenic and morphologic consideration. Am J Obstet Gynecol 104: 871, 1969
Norris HJ, Taylor HB: Luteoma of pregnancy. Am J Clin Pathol 47: 557, 1967
Verkauf BS, Reiter EO, Hernandez L, et al: Virilization of mother and fetus associated with luteoma of pregnancy: A case report with endocrinologic studies. Am J Obstet Gynecol 129: 274, 1977
Goldstein DP, Berkowitz RS: Gestational Trophoblastic Neoplasms. Philadelphia, Saunders, 1982
Morrow CP, Kletzky OA, DiSaia PJ, et al: Clinical and laboratory correlates of molar pregnancy and trophoblastic disease. Am J Obstet 128: 424, 1977
Li MC, Hertz R, Spencer DB: Effect of methotrexate therapy upon choriocarcinoma and chorioadenoma. Proc Soc Exp Biol Med 93: 361, 1956
Goldstein DP, Goldstein PR, Bottomley P, et al: Methotrexate with citrovorum rescue factor for non-metastatic gestational trophoblastic neoplasms. Obstet Gynecol 48: 321, 1976
Hammond CB, Parker RT: Diagnosis and treatment of trophoblastic disease. Obstet Gynecol 35: 132, 1970
Bagshawe KD: Treatment of trophoblastic tumors. Ann Acad Med 5: 273, 1976
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1987 Plenum Publishing Corporation
About this chapter
Cite this chapter
Chang, F.E., Kim, M.H. (1987). Hormone-Producing Tumors of the Ovary and Placenta. In: Gold, J.J., Josimovich, J.B. (eds) Gynecologic Endocrinology. Springer, Boston, MA. https://doi.org/10.1007/978-1-4613-2157-6_25
Download citation
DOI: https://doi.org/10.1007/978-1-4613-2157-6_25
Publisher Name: Springer, Boston, MA
Print ISBN: 978-1-4612-9272-2
Online ISBN: 978-1-4613-2157-6
eBook Packages: Springer Book Archive